TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34078209

Group type: EXPERIMENTAL
Intervention: Contextual interference group who putted at varied putting distances and had varied repetitive weekly schedule patterns
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Differential learning group who putted at multiple putting distances, putting amplitudes, and putting movements with no repetitions
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Identical differential learning as in (b) except that participants also varied the putter
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group who experienced no practice variations
Number of subjects: 42
Study: 36448744

Group type: EXPERIMENTAL
Intervention: Topical Jessner solution
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intralesional steroid
Number of subjects: 40

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 40
Study: 33029953

Group type: EXPERIMENTAL
Intervention: 4 × 30‐mg tablets
Number of subjects: 24

Group type: COMPARATOR
Intervention: 4 × 30‐mg tablets as slurry
Number of subjects: 24

Group type: COMPARATOR
Intervention: High-calorie/high-fat diet
Number of subjects: 24
Study: 33478294

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 33063273

Group type: EXPERIMENTAL
Intervention: Plenadren (once-daily dual-release hydrocortisone)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional hydrocortisone
Number of subjects: 30
Study: 36115321

Group type: EXPERIMENTAL
Intervention: Testosterone administration (single dose)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 140
Study: 32106877

Group type: EXPERIMENTAL
Intervention: 500 mL pleural lavage fluid
Number of subjects: 400

Group type: COMPARATOR
Intervention: 3000 mL pleural lavage fluid
Number of subjects: 400
Study: 34800061

Group type: EXPERIMENTAL
Intervention: Significant others' collateral PTSD reports
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Veterans' self-reported PTSD symptoms
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Gender composition of the couple
Number of subjects: 394

Group type: EXPERIMENTAL
Intervention: Exploratory subgroup analyses
Number of subjects: 394
Study: 32444880

Group type: EXPERIMENTAL
Intervention: Severe disease (defined as admission to the intensive care unit or death)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mechanical ventilation
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Overall mortality rate
Number of subjects: 105
Study: 34969428

Group type: EXPERIMENTAL
Intervention: Medication event reminder monitor system (MERM) with treatment monitor
Number of subjects: 106

Group type: COMPARATOR
Intervention: Usual strategy (control group)
Number of subjects: 106
Study: 34281997

Group type: EXPERIMENTAL
Intervention: Care management + portal
Number of subjects: 303

Group type: COMPARATOR
Intervention: Portal alone
Number of subjects: 303
Study: 33781008

Group type: EXPERIMENTAL
Intervention: Iberet Folic®
Number of subjects: 130

Group type: COMPARATOR
Intervention: Zincofer®
Number of subjects: 130

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 130
Study: 34793244

Group type: EXPERIMENTAL
Intervention: Black caregivers
Number of subjects: 722

Group type: EXPERIMENTAL
Intervention: White caregivers
Number of subjects: 722

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 722

Group type: COMPARATOR
Intervention: Multiple regression analyses
Number of subjects: 722
Study: 32922181

Group type: EXPERIMENTAL
Intervention: Oxycodone (OXY)
Number of subjects: 205

Group type: COMPARATOR
Intervention: Fentanyl (FEN)
Number of subjects: 205
Study: 32348963

Group type: EXPERIMENTAL
Intervention: Optical system for measuring acoustic startle reflex (ASR)
Number of subjects: 32

Group type: COMPARATOR
Intervention: EMG system
Number of subjects: 32
Study: 35512663

Group type: COMPARATOR
Intervention: Without a mask
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Surgical mask
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: FFP2 respirator
Number of subjects: 19
Study: 34048682

Group type: EXPERIMENTAL
Intervention: Camidanlumab tesirine (3–150 μg/kg, administered intravenously once every 3 weeks)
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Camidanlumab tesirine
Number of subjects: 133
Study: 35906582

Group type: EXPERIMENTAL
Intervention: recombinant human interleukin‐11 (rhIL‐11) mouthwash
Number of subjects: 112

Group type: COMPARATOR
Intervention: Kangfuxin fluid
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: routine oral care with rhIL‐11 mouthwash
Number of subjects: 112

Group type: COMPARATOR
Intervention: routine oral care
Number of subjects: 112
Study: 33740816

Group type: EXPERIMENTAL
Intervention: 0.33% ropivacaine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 100
Study: 34231179

Group type: EXPERIMENTAL
Intervention: Ataxic carriers
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Pre‐ataxic carriers
Number of subjects: 77

Group type: COMPARATOR
Intervention: Controls
Number of subjects: 77
Study: 34592390

Group type: EXPERIMENTAL
Intervention: Intensive structured self-monitoring of blood glucose (ISM)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Active control (AC)
Number of subjects: 0
Study: 36473029

Group type: EXPERIMENTAL
Intervention: Crocin (15 mg daily)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Sertraline (50 mg daily)
Number of subjects: 64
Study: 33604905

Group type: EXPERIMENTAL
Intervention: Picosecond alexandrite laser (PSAL) with diffractive lens array (DLA)
Number of subjects: 10
Study: 32660526

Group type: EXPERIMENTAL
Intervention: Peri-operative exercise programme
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard care (no formal exercise advice)
Number of subjects: 0
Study: 34343420

Group type: EXPERIMENTAL
Intervention: Low dose of hypertonic saline (0.5 ml)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: High dose of hypertonic saline (1.0 ml)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Non-drawing group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Drawing group
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Momentary pain drawings
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Peak pain intensity
Number of subjects: 57
Study: 34746427

Group type: EXPERIMENTAL
Intervention: SaeboGlove plus usual care
Number of subjects: 110

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 110
Study: 32865025

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei Shirota (LcS)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 35219762

Group type: EXPERIMENTAL
Intervention: Calorie restriction (CR) 25% for 2 years
Number of subjects: 103

Group type: COMPARATOR
Intervention: Standard diet (SD)
Number of subjects: 103
Study: 33116482

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1,100 µg F−/g
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 1,100 µg F−/g + nano‐HA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5,000 µg F−/g
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 5,000 µg F−/g + nano‐HA
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: nano‐HA without F−
Number of subjects: 60
Study: 36069112

Group type: EXPERIMENTAL
Intervention: Toothbrush A
Number of subjects: 18

Group type: COMPARATOR
Intervention: Toothbrush B
Number of subjects: 18
Study: 34915541

Group type: EXPERIMENTAL
Intervention: Extracorporeal shockwave therapy
Number of subjects: 36
Study: 32131642

Group type: EXPERIMENTAL
Intervention: Capacitive and resistive electric transfer (CRet)
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Hot pack (HP)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Sham CRet
Number of subjects: 28
Study: 35745241

Group type: EXPERIMENTAL
Intervention: PRS (resistant starch)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PRS and KON (konjaku flour)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PRS and KON
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: PRS
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Defecation frequency and serum 5‐HT
Number of subjects: 80
Study: 33900322

Group type: EXPERIMENTAL
Intervention: Oatmeal products with low β-glucan viscosity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oatmeal products with medium β-glucan viscosity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oatmeal products with high β-glucan viscosity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kilned samples tempered to 25% moisture and microwaved for 2 minutes
Number of subjects: 0
Study: 32306477

Group type: EXPERIMENTAL
Intervention: Faster aspart (0.2 U/kg, single-dose subcutaneous)
Number of subjects: 43

Group type: COMPARATOR
Intervention: IAsp (0.2 U/kg, single-dose subcutaneous)
Number of subjects: 43
Study: 35210345

Group type: EXPERIMENTAL
Intervention: Perturbation-based balance training (PBT) protocol, three sessions
Number of subjects: 16
Study: 32780994

Group type: EXPERIMENTAL
Intervention: Combined low-level laser (LLL) and light-emitting diode (LED) irradiation
Number of subjects: 40
Study: 32004201

Group type: EXPERIMENTAL
Intervention: Rapid hemorrhage (1.4 ml/min, 30‐min bleeding)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Rapid‐L hemorrhage (1.4 ml/min, 30‐min bleeding and observation until 6 h)
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Slow hemorrhage (0.1 ml/min, intermittently, 6‐h bleeding)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control (30‐min observation)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Control‐L (6‐h observation)
Number of subjects: 5
Study: 33934431

Group type: EXPERIMENTAL
Intervention: Ramucirumab plus erlotinib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus erlotinib
Number of subjects: 0
Study: 33969505

Group type: EXPERIMENTAL
Intervention: Early pacemaker implantation (<7 days)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Late pacemaker implantation (≥7 days)
Number of subjects: 108
Study: 35123855

Group type: EXPERIMENTAL
Intervention: Wheat Aleurone Diet
Number of subjects: 23

Group type: COMPARATOR
Intervention: Refined Wheat Diet
Number of subjects: 23
Study: 32618250

Group type: EXPERIMENTAL
Intervention: Recent travel to high-prevalence areas
Number of subjects: 602620

Group type: EXPERIMENTAL
Intervention: Long-lasting insecticidal net usage while traveling
Number of subjects: 602620

Group type: EXPERIMENTAL
Intervention: Short-term travel overall
Number of subjects: 602620
Study: 35813851

Group type: EXPERIMENTAL
Intervention: 28 mg daily of saffron extract (affron®)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 62
Study: 33823845

Group type: EXPERIMENTAL
Intervention: Teaching of the fusion of the original CT and MR data 3D model and the original image combined with 3D anatomical image
Number of subjects: 460

Group type: COMPARATOR
Intervention: Control group teaching method (not specified)
Number of subjects: 460
Study: 36410825

Group type: EXPERIMENTAL
Intervention: Periodontal treatment and colchicine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Periodontal treatment only
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Colchicine only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control/delayed periodontal treatment
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60
Study: 32075474

Group type: EXPERIMENTAL
Intervention: Butyphthalide injection combined with urinary kallikrein
Number of subjects: 110

Group type: COMPARATOR
Intervention: Cinepazide maleate injection combined with alprostadil injection
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 110
Study: 32087356

Group type: EXPERIMENTAL
Intervention: Combined endocardial/epicardial mapping and ablation (endo/epi)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Endocardial mapping and ablation (endo)
Number of subjects: 30
Study: 35581997

Group type: EXPERIMENTAL
Intervention: High-dose melatonin (21 mg per day for 5 days)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 32138784

Group type: EXPERIMENTAL
Intervention: 0.5 μg/kg dexmedetomidine (DEX2)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Placebo (normal saline)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: All groups (including DEX1, DEX2, and Placebo)
Number of subjects: 126
Study: 616117878

Group type: EXPERIMENTAL
Intervention: Ranibizumab
Number of subjects: 973

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 973
Study: 36250283

Group type: EXPERIMENTAL
Intervention: Preoperative multimodal nutrition intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 49
Study: 35804297

Group type: EXPERIMENTAL
Intervention: Stay Strong app
Number of subjects: 156
Study: 34129855

Group type: EXPERIMENTAL
Intervention: Androgen-deprivation therapy (ADT) + docetaxel (D)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Androgen-deprivation therapy (ADT) alone
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Higher Decipher risk and lower AR-A
Number of subjects: 160
Study: 33516592

Group type: EXPERIMENTAL
Intervention: Tailored, stage-matched intervention
Number of subjects: 533

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 533

Group type: EXPERIMENTAL
Intervention: Self-efficacy instrument (SE-HTA)
Number of subjects: 533
Study: 32249788

Group type: EXPERIMENTAL
Intervention: Repetitive peripheral magnetic stimulation (rPMS) applied to the trapezius muscles (n=19)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Repetitive peripheral magnetic stimulation (rPMS) applied to the deltoid muscles (n=18)
Number of subjects: 37
Study: 35473663

Group type: EXPERIMENTAL
Intervention: Low-dose rFSAV (60 μg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Middle-dose rFSAV (120 μg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: High-dose rFSAV (240 μg)
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Dose-adjusted rFSAV (90 μg) in phase 1b
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: All rFSAV doses
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 35000952

Group type: EXPERIMENTAL
Intervention: XP‐endo Finisher R (XPF‐R)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: WaveOne Gold (WOG)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: TruNatomy (TRN)
Number of subjects: 30
Study: 36497687

Group type: EXPERIMENTAL
Intervention: Individualized oral health care training (IndOHCT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Information flyer (Control group)
Number of subjects: 74
Study: 33248282

Group type: EXPERIMENTAL
Intervention: sIgE to Ara h 2
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: sIgE to Ara h 6
Number of subjects: 154

Group type: EXPERIMENTAL
Intervention: sIgE to peanut extract
Number of subjects: 154
Study: 32701900

Group type: EXPERIMENTAL
Intervention: Snus (8 mg nicotine)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 36145080

Group type: EXPERIMENTAL
Intervention: BR (11.8 mmol NO3− per day)
Number of subjects: 14

Group type: COMPARATOR
Intervention: PL (0.10 mmol NO3− per day)
Number of subjects: 14
Study: 32941386

Group type: EXPERIMENTAL
Intervention: Animal-based research articles post-ARRIVE guidelines
Number of subjects: 100

Group type: COMPARATOR
Intervention: Animal-based research articles pre-ARRIVE guidelines
Number of subjects: 100
Study: 35476860

Group type: EXPERIMENTAL
Intervention: 0.7-mm transmucosal abutment height
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 2.4-mm transmucosal abutment height
Number of subjects: 60
Study: 33949940

Group type: EXPERIMENTAL
Intervention: Progestogen-only pill (75 microg of desogestrel) plus rapid access card to a sexual and reproductive health clinic
Number of subjects: 636

Group type: COMPARATOR
Intervention: Control group advised to attend their usual contraceptive provider
Number of subjects: 636
Study: 33250388

Group type: EXPERIMENTAL
Intervention: Closed-suction drainage (Group 1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control (no drainage) (Group 2)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Both groups (G1 and G2)
Number of subjects: 150
Study: 36471334

Group type: EXPERIMENTAL
Intervention: Spinal manipulation or medical care (specific types not detailed)
Number of subjects: 90
Study: 33320067

Group type: EXPERIMENTAL
Intervention: TARE with US-triggered microbubble destruction
Number of subjects: 28

Group type: COMPARATOR
Intervention: TARE
Number of subjects: 28
Study: 33893754

Group type: EXPERIMENTAL
Intervention: evolocumab 140 mg s.c. every 2 weeks on top of ongoing LLT
Number of subjects: 100

Group type: COMPARATOR
Intervention: ongoing LLT alone
Number of subjects: 100
Study: 32742642

Group type: EXPERIMENTAL
Intervention: 2RDA (2 times the recommended dietary intake of protein, 1.6 g protein/kg body weight per day)
Number of subjects: 28

Group type: COMPARATOR
Intervention: RDA (recommended dietary intake of protein, 0.8 g protein/kg body weight per day)
Number of subjects: 28
Study: 34474421

Group type: EXPERIMENTAL
Intervention: Bruch membrane opening-minimum rim width (BMO-MRW)
Number of subjects: 253

Group type: COMPARATOR
Intervention: peripapillary retinal nerve fiber layer (pRNFL) thickness
Number of subjects: 253
Study: 36513483

Group type: EXPERIMENTAL
Intervention: L-Arg supplementation (3 g oral daily for up to 10 days)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study: 33206991

Group type: EXPERIMENTAL
Intervention: Nivolumab plus Ipilimumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Chemotherapy (pemetrexed and cisplatin or carboplatin)
Number of subjects: 0
Study: 33949711

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no diet change)
Number of subjects: 0
Study: 32162109

Group type: EXPERIMENTAL
Intervention: Ilioinguinal–iliohypogastric nerve block (IINB and IHNB) with tumescent anaesthesia
Number of subjects: 75

Group type: COMPARATOR
Intervention: Spinal anaesthesia
Number of subjects: 75
Study: 35971267

Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Absorbable gelatine
Number of subjects: 29
Study: 33984498

Group type: EXPERIMENTAL
Intervention: Foot reflexology (20 min sessions, 4 times over 2 weeks)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo foot reflexology (noneffective touch, 20 min sessions, 4 times over 2 weeks)
Number of subjects: 45
Study: 32151214

Group type: EXPERIMENTAL
Intervention: Video psychoeducation
Number of subjects: 556

Group type: COMPARATOR
Intervention: Informational brochure
Number of subjects: 556
Study: 35724841

Group type: EXPERIMENTAL
Intervention: Public Commitment
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Private Commitment
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Benchmark Peer Comparison
Number of subjects: 1530

Group type: EXPERIMENTAL
Intervention: Trending
Number of subjects: 1530

Group type: COMPARATOR
Intervention: Control (Commitment)
Number of subjects: 1530

Group type: COMPARATOR
Intervention: Control (Performance Feedback)
Number of subjects: 1530
Study: 34333991

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training plus moderate caloric restriction (CR); n=55
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training plus more intensive caloric restriction (CR); n=49
Number of subjects: 160

Group type: COMPARATOR
Intervention: Aerobic exercise training only; n=56
Number of subjects: 160
Study: 35701050

Group type: EXPERIMENTAL
Intervention: Targeted expectation management aiming to reduce illness-related anxiety and dysfunctional symptom expectations in addition to standard care (SC)
Number of subjects: 234

Group type: EXPERIMENTAL
Intervention: Non-specific supportive treatment in addition to standard care (SC)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Standard care (SC) only
Number of subjects: 234
Study: 33267769

Group type: EXPERIMENTAL
Intervention: Oral mosapride (5 mg) before and after surgery with dexamethasone (10 mg)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Dexamethasone (10 mg) before anesthesia induction
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 35723120

Group type: EXPERIMENTAL
Intervention: Low-frequency repetitive transcranial magnetic stimulation (rTMS) combined with functional electrical stimulation (FES)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Low-frequency repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Functional electrical stimulation (FES)
Number of subjects: 60
Study: 33845869

Group type: EXPERIMENTAL
Intervention: Gentle Years Yoga (GYY) programme for 12 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: No offer (control group)
Number of subjects: 0
Study: 32750714

Group type: EXPERIMENTAL
Intervention: Project SEARCH plus ASD Supports (PS+ASD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PS+ASD
Number of subjects: 0
Study: 35532982

Group type: EXPERIMENTAL
Intervention: Escitalopram
Number of subjects: 51

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 51
Study: 34111564

Group type: EXPERIMENTAL
Intervention: EV-naive
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: EV-RIPC
Number of subjects: 30
Study: 35147087

Group type: EXPERIMENTAL
Intervention: Electro-press needle (EPN) treatment, 3 sessions per week for 6 weeks (total of 18 sessions)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Waitlist control group (no intervention for the first 6 weeks)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: EPN treatment
Number of subjects: 122
Study: 34019214

Group type: EXPERIMENTAL
Intervention: CAPOXIRI plus bevacizumab (irinotecan 200 mg/m2, oxaliplatin 100 mg/m2, capecitabine 1600 mg/m2, bevacizumab 7.5 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: CAPOXIRI plus bevacizumab (irinotecan 200 mg/m2, oxaliplatin 130 mg/m2, capecitabine 1600 mg/m2, bevacizumab 7.5 mg/kg)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: All patients receiving CAPOXIRI plus bevacizumab
Number of subjects: 9
Study: 33086291

Group type: EXPERIMENTAL
Intervention: Central topography (CT) from IOLMaster 700
Number of subjects: 105

Group type: COMPARATOR
Intervention: Predicate topographic maps (PT) from a Placido‐dual‐Scheimpflug tomographer
Number of subjects: 105